Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Enlivex Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −4 vs. Q2 2022
- Shares held
- 333.6K
- −271.1K (−44.8%) vs. Q2 2022
- Total value
- $1.41M
- −$1.48M (−51.1%) vs. Q2 2022
- New holders
- 2
- 4 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 58,889 | $250.0K | 0.00% | −5,300−8.3% | Reduced |
| Compagnie Lombard Odier SCmA | 50,000 | $211.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 44,516 | $189.0K | 0.00% | +11,791+36.0% | Added |
| Citadel Advisors LLC | 39,554 | $168.0K | 0.00% | +39,554 | New |
| UBS Group AG | 31,871 | $136.0K | 0.00% | +13,490+73.4% | Added |
| Goldman Sachs Group Inc | 20,729 | $88.0K | 0.00% | +20,729 | New |
| Susquehanna International Group Ltd. | 20,299 | $85.0K | 0.03% | −1,703−7.7% | Reduced |
| Wells Fargo & Company | 18,054 | $77.0K | 0.00% | +5,681+45.9% | Added |
| ACT Capital Management, LLC | 15,000 | $64.0K | 0.09% | 00.0% | Unchanged |
| Edmond de Rothschild Holding S.A. | 13,000 | $55.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,420 | $44.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,126 | $21.0K | 0.00% | +821+19.1% | Added |
| Steward Partners Investment Advisory, LLC | 3,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 750 | $3.00K | 0.00% | −465−38.3% | Reduced |
| Group One Trading, L.P. | 484 | $2.00K | 0.00% | −2,400−83.2% | Reduced |
| Umb Bank N A | 550 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $2.00K | 0.00% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −331,001−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −21,887−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Ahrens Investment Partners LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |